DK0699185T3 - Guanidinderivater som inhibitorer af Na+/H+-udskiftning i celler - Google Patents

Guanidinderivater som inhibitorer af Na+/H+-udskiftning i celler

Info

Publication number: DK0699185T3
Authority: DK; Denmark
Prior art keywords: hydroxy; pct; hydrogen; cells; protected
Prior art date: 1993-05-17

Application number

DK94914623T

Other languages

English (en)

Inventor

Atsushi Kuno

Yoshikazu Inoue

Hisashi Takasugi

Hiroaki Mizuno

Kumi Yamasaki

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-17

Filing date

1994-05-12

Publication date

2001-11-12

1993-05-17 Priority claimed from GB939310074A external-priority patent/GB9310074D0/en

1993-12-10 Priority claimed from GB939325268A external-priority patent/GB9325268D0/en

1994-05-12 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

2001-11-12 Application granted granted Critical

2001-11-12 Publication of DK0699185T3 publication Critical patent/DK0699185T3/da

Links

150000002357 guanidines Chemical class 0.000 title 1
229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 6
150000002431 hydrogen Chemical group 0.000 abstract 4
229910052739 hydrogen Inorganic materials 0.000 abstract 4
239000001257 hydrogen Substances 0.000 abstract 4
125000003545 alkoxy group Chemical group 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
208000024172 Cardiovascular disease Diseases 0.000 abstract 1
206010038372 Renal arteriosclerosis Diseases 0.000 abstract 1
208000026106 cerebrovascular disease Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
208000017169 kidney disease Diseases 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
-1 nitro, hydroxy Chemical group 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
125000003226 pyrazolyl group Chemical group 0.000 abstract 1
125000000168 pyrrolyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
230000035939 shock Effects 0.000 abstract 1
125000003831 tetrazolyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Compositions Of Macromolecular Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Filtering Materials (AREA)
Furan Compounds (AREA)
Pyrrole Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Pyridine Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)

DK94914623T 1993-05-17 1994-05-12 Guanidinderivater som inhibitorer af Na+/H+-udskiftning i celler DK0699185T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB939310074A GB9310074D0 (en)	1993-05-17	1993-05-17	Guanidine derivatives
GB939325268A GB9325268D0 (en)	1993-12-10	1993-12-10	Guanidine derivatives
PCT/JP1994/000786 WO1994026709A1 (en)	1993-05-17	1994-05-12	GUANIDINE DERIVATIVES AS INHIBITORS OF Na+/H+ EXCHANGE IN CELLS

Publications (1)

Publication Number	Publication Date
DK0699185T3 true DK0699185T3 (da)	2001-11-12

Family

ID=26302902

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94914623T DK0699185T3 (da)	1993-05-17	1994-05-12	Guanidinderivater som inhibitorer af Na+/H+-udskiftning i celler

Country Status (17)

Country	Link
US (1)	US5824691A (da)
EP (1)	EP0699185B1 (da)
JP (1)	JPH08511243A (da)
KR (1)	KR100315759B1 (da)
CN (1)	CN1080257C (da)
AT (1)	ATE205191T1 (da)
AU (1)	AU685457B2 (da)
CA (1)	CA2163004A1 (da)
DE (1)	DE69428198T2 (da)
DK (1)	DK0699185T3 (da)
ES (1)	ES2159558T3 (da)
GR (1)	GR3036549T3 (da)
HU (1)	HUT70206A (da)
IL (1)	IL109570A0 (da)
PT (1)	PT699185E (da)
RU (1)	RU2141946C1 (da)
WO (1)	WO1994026709A1 (da)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4332384A1 (de) *	1993-09-23	1995-03-30	Merck Patent Gmbh	Adhäsionsrezeptor-Antagonisten III
IL114670A0 (en) *	1994-08-05	1995-11-27	Fujisawa Pharmaceutical Co	Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
DK0723956T3 (da) *	1995-01-30	2000-04-17	Hoechst Ag	Basisk substituerede benzoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnos
US6057322A (en) *	1995-01-30	2000-05-02	Hoechst Aktiengesellschaft	Basically-substituted benzoylguanidines, a process for preparing them, their use as a medicament or diagnostic agent, and a medicament containing them
US5627193A (en) *	1995-02-09	1997-05-06	Mitsui Toatsu Chemicals, Inc.	Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
EP0765867A1 (de) *	1995-09-27	1997-04-02	Hoechst Aktiengesellschaft	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament
DE19540995A1 (de) *	1995-11-03	1997-05-07	Hoechst Ag	Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) *	1995-11-14	1997-05-15	Hoechst Ag	Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PL316438A1 (en) *	1995-11-20	1997-05-26	Hoechst Ag	Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
PL316439A1 (en)	1995-11-20	1997-05-26	Hoechst Ag	Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
DE19546736A1 (de) *	1995-12-14	1997-06-19	Hoechst Ag	Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
GB9600063D0 (en) *	1996-01-03	1996-03-06	Fujisawa Pharmaceutical Co	Guaridine derivatives
WO1997027183A1 (en) *	1996-01-26	1997-07-31	Fujisawa Pharmaceutical Co., Ltd.	Guanidine derivatives
DE19603425A1 (de) *	1996-01-31	1997-08-07	Hoechst Ag	Substituierte Diaryldicarbonsäure-diguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CA2195697A1 (en) *	1996-02-02	1997-08-03	Masahumi Kitano	Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof
DE19608162A1 (de) *	1996-03-04	1997-09-11	Hoechst Ag	Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JPH09291076A (ja) *	1996-04-24	1997-11-11	Sumitomo Pharmaceut Co Ltd	置換グアニジン誘導体およびその製法
DE19621482A1 (de)	1996-05-29	1997-12-04	Hoechst Ag	Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621483A1 (de) *	1996-05-29	1997-12-04	Hoechst Ag	Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CA2283404A1 (en) *	1997-03-06	1998-09-11	Jun Sasamori	Cycloalka¬b\|pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same
DE19721031A1 (de) *	1997-05-20	1998-11-26	Bayer Ag	Substituierte Pyridylpyrazole
JP2002502414A (ja) *	1997-06-02	2002-01-22	藤沢薬品工業株式会社	細胞中のＮａ▲上＋▼／Ｈ▲上＋▼交換の阻害剤としてのグアニジン誘導体
DE19737224A1 (de) *	1997-08-27	1999-03-18	Hoechst Marion Roussel De Gmbh	Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen
JP2002504546A (ja)	1998-02-27	2002-02-12	ファイザー・プロダクツ・インク	虚血の治療のためのｎ−［（置換５員ジもしくはトリアザ二不飽和環）カルボニル］グアニジン誘導体
WO2000069811A1 (en) *	1999-05-17	2000-11-23	Teijin Limited	Cyanobiphenyl derivatives
WO2001044186A1 (en) *	1999-12-16	2001-06-21	Sumitomo Pharmaceuticals Company, Limited	Substituted guanidine derivatives
DE10024319A1 (de) *	2000-05-17	2001-11-22	Merck Patent Gmbh	Bisacylguanidine
CY2010012I2 (el)	2000-05-25	2020-05-29	Novartis Ag	Μιμητικα θρομβοποιητινης
DE10061876A1 (de) *	2000-12-12	2002-06-20	Aventis Pharma Gmbh	Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
JP2005500351A (ja) *	2001-07-30	2005-01-06	ドクター・レディーズ・ラボラトリーズ・リミテッド	結晶形態ｖｉおよびｖｉｉのアトルバスタチンカルシウム
MY142390A (en)	2002-05-22	2010-11-30	Glaxosmithkline Llc	3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
FR2842524B1 (fr) *	2002-07-16	2005-04-22	Aventis Pharma Sa	Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-pyrrole, leur procede de preparation a titre de medicaments
AU2003294275A1 (en) *	2002-11-21	2004-06-18	New York Blood Center	Compounds for inhibition of hiv infection by blocking hiv entry
ATE440827T1 (de)	2002-12-04	2009-09-15	Ore Pharmaceuticals Inc	Melanocortin-rezeptormodulatoren
EP1620394B1 (de) *	2003-05-06	2008-08-13	MERCK PATENT GmbH	Verfahren zur kristallisation von guanidinium-salzen
TW200526638A (en)	2003-10-22	2005-08-16	Smithkline Beecham Corp	2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
US8669280B2 (en)	2005-06-24	2014-03-11	Biotron Limited	Antiviral compounds and methods
AU2013205388B2 (en) *	2005-06-24	2016-05-05	Biotron Limited	Antiviral compounds and methods
CN100371328C (zh) *	2006-01-19	2008-02-27	中国药科大学	取代苯甲酰基胍衍生物、其制备方法及其医药用途
ES2596706T3 (es)	2006-06-29	2017-01-11	F. Hoffmann-La Roche Ag	Arilamidas con sustitución de tetrazol
MX2009010491A (es) *	2007-04-11	2009-11-09	Kissei Pharmaceutical	Derivado heterociclico de 5 miembros y su uso para propositos medicos.
ECSP077628A (es)	2007-05-03	2008-12-30	Smithkline Beechman Corp	Nueva composición farmacéutica
KR101186704B1 (ko) *	2007-10-04	2012-09-27	에프. 호프만-라 로슈 아게	테트라졸-치환된 아릴 아마이드 유도체 및 이의 용도
BR122019016794B8 (pt)	2007-12-17	2021-07-27	Hoffmann La Roche	derivados de arilamida substituídos por tetrazol, composição farmacêutica que os compreende e seu uso no tratamento de uma condição inflamatória e/ou autoimune
DK2234976T3 (da)	2007-12-17	2013-06-24	Hoffmann La Roche	Nye pyrazol-substituerede arylamider
KR101405746B1 (ko)	2007-12-17	2014-06-10	에프. 호프만-라 로슈 아게	트리아졸 치환된 아릴아미드 유도체 및 ｐ２ｘ３ 및/또는 ｐ２ｘ２／３ 퓨린성 수용체 길항제로서의 용도
ES2570628T3 (es)	2007-12-17	2016-05-19	Hoffmann La Roche	Nuevas arilamidas con sustitución imidazol
WO2018129556A1 (en)	2017-01-09	2018-07-12	Ardelyx, Inc.	Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
CN103819403B (zh)	2008-12-31	2017-01-04	阿德利克斯公司	用于治疗与体液潴留或盐超负荷有关的病症和胃肠道病症的化合物和方法
EP2434894B1 (en)	2009-05-29	2016-08-31	Novartis AG	Methods of administration of thrombopoietin agonist compounds
EP2445897B1 (en)	2009-06-22	2014-03-19	F.Hoffmann-La Roche Ag	Novel indazole arylamides as p2x3 and/or p2x2/3 antagonists
EP2445868B1 (en)	2009-06-22	2013-12-18	F.Hoffmann-La Roche Ag	Biphenyl amides useful as p2x3 and/or p2x2/3 receptors modulators
CA2754654A1 (en)	2009-06-22	2010-12-29	F. Hoffmann-La Roche Ag	Novel oxazolone and pyrrolidinone-substituted arylamides
US9090584B2 (en)	2010-01-26	2015-07-28	Allergan, Inc.	Therapeutic agents for treatment of ocular hypertension
US10376481B2 (en)	2012-08-21	2019-08-13	Ardelyx, Inc.	Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
RU2015107019A (ru)	2012-08-21	2016-10-10	Эрделикс Инк.	Соединения и способы для ингибирования nhe-опосредованного антипорта в лечении расстройств, ассоциированных с задержкой жидкости или солевой перегрузкой и заболеваний желудочно-кишечного тракта
CN105392483B (zh)	2013-04-12	2019-03-15	阿德利克斯公司	用于抑制磷酸盐转运的nhe3结合化合物和方法
EA201991676A1 (ru)	2017-01-09	2020-01-30	Арделикс, Инк.	Ингибиторы nhe-опосредованного антипорта
KR20240090875A (ko)	2017-01-09	2024-06-21	알데릭스, 인코포레이티드	위장관 장애를 치료하는 데 유용한 화합물
CN111386279A (zh)	2017-08-04	2020-07-07	阿德利克斯股份有限公司	用于治疗高钾血症的甘草次酸衍生物
JP7735185B2 (ja)	2019-02-07	2025-09-08	アルデリックス，インコーポレイテッド	高カリウム血症の治療で使用するためのグリチルレチン酸誘導体
JP2022533251A (ja)	2019-05-21	2022-07-21	アルデリックス，インコーポレイテッド	患者において血清リン酸塩を低下させるための組み合わせ
CN113527672B (zh) *	2020-03-30	2022-09-20	复旦大学	一种胍基衍生物及其基因递释系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1619538B1 (de) *	1967-08-04	1971-06-24	Bayer Ag	Verfahren zum Färben von Fasermaterialien aus Polyacrylnitril oder acrylnitrilhaltigen Mischpolymerisaten
US4251545A (en) *	1979-09-19	1981-02-17	Gaf Corporation	Fungicidal process using 1-(alkoxyaroyl)guanidines
ATE24997T1 (de) *	1982-01-04	1987-02-15	Karl H Beyer Jr	Hyperueretische mittel.
JPS59106993A (ja) *	1982-12-10	1984-06-20	Ricoh Co Ltd	ジアゾ系感熱記録材料
TW213903B (da) *	1991-08-16	1993-10-01	Boehringer Ingelheim Kg
ATE158278T1 (de) *	1992-02-15	1997-10-15	Hoechst Ag	Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
EP0556674B1 (de) *	1992-02-15	1996-06-19	Hoechst Aktiengesellschaft	3,5-Substituierte Benzoylguanidine, mit antiarrythmischer Wirkung und inhibierender Wirkung auf die Proliferationen von Zellen
CZ284456B6 (cs) *	1992-02-15	1998-12-16	Hoechst Aktiengesellschaft	Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
DK0577024T3 (da) *	1992-07-01	1997-02-24	Hoechst Ag
ES2100435T3 (es) *	1992-12-16	1997-06-16	Hoechst Ag	Aminobenzoilguanidinas 3,5-sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.
DE59403818D1 (de) *	1993-02-20	1997-10-02	Hoechst Ag	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, als Inhibitoren des zellulären Na+/H+-Austauschs oder als Diagnostikum sowie sie enthaltendes Medikament
DE4318658A1 (de) *	1993-06-04	1994-12-08	Hoechst Ag	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4318756A1 (de) *	1993-06-05	1994-12-08	Hoechst Ag	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4325822A1 (de) *	1993-07-31	1995-02-02	Hoechst Ag	Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4327244A1 (de) *	1993-08-13	1995-02-16	Hoechst Ag	Harnstoffsubstituierte Benzoylguandine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) *	1993-08-27	1995-03-02	Hoechst Ag	Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

1994
- 1994-05-05 IL IL10957094A patent/IL109570A0/xx unknown
- 1994-05-12 DK DK94914623T patent/DK0699185T3/da active
- 1994-05-12 AU AU66912/94A patent/AU685457B2/en not_active Ceased
- 1994-05-12 CN CN94192121A patent/CN1080257C/zh not_active Expired - Fee Related
- 1994-05-12 AT AT94914623T patent/ATE205191T1/de not_active IP Right Cessation
- 1994-05-12 RU RU95122558A patent/RU2141946C1/ru active
- 1994-05-12 EP EP94914623A patent/EP0699185B1/en not_active Expired - Lifetime
- 1994-05-12 ES ES94914623T patent/ES2159558T3/es not_active Expired - Lifetime
- 1994-05-12 JP JP6525245A patent/JPH08511243A/ja active Pending
- 1994-05-12 PT PT94914623T patent/PT699185E/pt unknown
- 1994-05-12 DE DE69428198T patent/DE69428198T2/de not_active Expired - Fee Related
- 1994-05-12 CA CA002163004A patent/CA2163004A1/en not_active Abandoned
- 1994-05-12 KR KR1019950704730A patent/KR100315759B1/ko not_active Expired - Fee Related
- 1994-05-12 US US08/532,804 patent/US5824691A/en not_active Expired - Fee Related
- 1994-05-12 WO PCT/JP1994/000786 patent/WO1994026709A1/en not_active Ceased
- 1994-05-12 HU HU9403233A patent/HUT70206A/hu unknown
2001
- 2001-09-06 GR GR20010401402T patent/GR3036549T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
HUT70206A (en)	1995-09-28
CN1123545A (zh)	1996-05-29
PT699185E (pt)	2002-01-30
KR960701841A (ko)	1996-03-28
WO1994026709A1 (en)	1994-11-24
US5824691A (en)	1998-10-20
EP0699185B1 (en)	2001-09-05
DE69428198D1 (de)	2001-10-11
KR100315759B1 (ko)	2002-04-06
AU685457B2 (en)	1998-01-22
RU2141946C1 (ru)	1999-11-27
DE69428198T2 (de)	2002-03-28
CA2163004A1 (en)	1994-11-24
ES2159558T3 (es)	2001-10-16
CN1080257C (zh)	2002-03-06
JPH08511243A (ja)	1996-11-26
IL109570A0 (en)	1994-08-26
GR3036549T3 (en)	2001-12-31
ATE205191T1 (de)	2001-09-15
AU6691294A (en)	1994-12-12
EP0699185A1 (en)	1996-03-06

Publication	Publication Date	Title
GR3036549T3 (en)	2001-12-31	GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS
TW260669B (da)	1995-10-21
ATE231143T1 (de)	2003-02-15	Triarylimidazole
AU6264194A (en)	1994-10-24	Nitrogen-containing fused-heterocycle compounds
DK0677046T3 (da)	1997-09-01	Piperazinderivater som 5-HT-antagonister.
GB9514518D0 (en)	1995-09-13	Guanidine salt inhibitors of NO synthase and cyclooxygenase
NO20035210D0 (no)	2003-11-24	2-anilino-pyrimidinderivater som cyklinavhengige kinaseinhibitorer
ATE148108T1 (de)	1997-02-15	Beta,beta-dimethyl-4-piperidinethanamin-derivat als inhibitoren der cholesterin-biosynthese
IL110040A0 (en)	1994-10-07	Pyridazinone derivatives
GB9313330D0 (en)	1993-08-11	New compound and its preparation
AUPN952696A0 (en)	1996-05-23	New heterocyclic compounds
NO20022123L (no)	2002-05-03	Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
DK0689534T3 (da)	2003-02-03	Amidderivater som 5-HT1A-ligander
HRP20010885B1 (en)	2010-07-31	Ethanesulfonyl-piperidine derivatives
IL110845A0 (en)	1994-11-28	Pyridazinone derivatives or their salts, processes or their production and anti-shock agents containing them
IL108288A0 (en)	1994-04-12	Pyrrolidine derivatives, their preparation and medicaments containing them
ATE202108T1 (de)	2001-06-15	Cephemverbindungen
GB9308431D0 (en)	1993-06-09	Chemical compounds
TW289019B (da)	1996-10-21